We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Entellus Medical, Inc. (NASDAQ: ENTL) to Stryker Corporation (NYSE: SYK) for $24 in cash per share.
The investigation concerns whether the Board of Entellus breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Stryker Corporation is underpaying for Entellus shares, thus unlawfully harming Entellus shareholders.
To receive more information, please fill out the form.